POLAN MARY LAKE PH D 4

What Happened

• Mary Lake Polan, Ph.D., a director of QuidelOrtho Corporation (QDEL), was granted a total of 22,743 restricted stock units (RSUs) on June 25, 2026. The award was reported as three separate grants: 15,532 RSUs, 5,547 RSUs, and 1,664 RSUs. Each RSU represents the right to one share; the reported acquisition price was $0.00 (awarded in lieu of cash).

Key Details

• Transaction date: June 25, 2026; Filing date: June 29, 2026 (timely).
• Grant amounts: 15,532 RSUs + 5,547 RSUs + 1,664 RSUs = 22,743 RSUs; reported price $0.00 (derivative award).
• Vesting/deferral: Footnote F2 states the RSUs will vest on June 25, 2027. Footnote F3 notes these RSUs were issued in lieu of cash retainer/board fees under a deferred compensation program and that release of vested RSUs will follow the officer’s elected deferral schedule.
• Additional vesting detail (per filing): Footnote F4 shows a staggered vesting of 1,386 shares vested on 6/25/2026 and 1,387 shares vesting on 9/25/2026, 12/25/2026, and 3/25/2027 (these amounts total 5,547 RSUs).
• Shares owned after the transaction: not specified in the provided filing details.

Context

• These are derivative awards (RSUs), not open-market purchases or sales. RSUs convey the right to receive common stock upon vesting and are commonly used to compensate non-employee directors; receiving RSUs in lieu of cash does not itself indicate a bullish or bearish signal. The filing appears timely (filed within required business days).